Formative work to develop differentiated communication tools to facilitate transgender women's recruitment, enrollment, and retention in HIV vaccine trials

Pharmacology, Toxicology and Pharmaceutical Science

1. HIV 66%
2. Human Immunodeficiency Virus Vaccine 100%
3. Prevalence 33%
4. Tolerability 66%